Following the promising preliminary clinical results, showing the ability of Alpha DaRT to effectively and safely destroy solid tumors, Alpha Tau Medical raises more capital than planned. Alpha Tau Medical Ltd. has raised 20% more capital than planned for its Alpha DaRT cancer treatment. The funding will be used to further develop the Alpha DaRT as a highly potent and conformal treatment for 11 different types of solid tumors. The preliminary results of its first clinical stu